Cardiff Oncology Inc (CRDF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,710 | -8,213 | -4,089 | -16,414 | -12,172 |
| Depreciation Amortization | 349 | 234 | 119 | 494 | 373 |
| Accounts receivable | -1 | 94 | 97 | -36 | 16 |
| Other Working Capital | -739 | -727 | 128 | 1,092 | 711 |
| Other Operating Activity | 1,910 | 947 | 371 | 1,596 | 1,081 |
| Operating Cash Flow | $-11,191 | $-7,665 | $-3,374 | $-13,268 | $-9,991 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -154 | N/A | N/A | -68 | -68 |
| Investing Cash Flow | $-154 | $N/A | $N/A | $-68 | $-68 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 305 | 305 | N/A | N/A | N/A |
| Common Stock Issued | 37,258 | 24,928 | 2,456 | 12,117 | 7,677 |
| Other Financing Activity | -8 | -8 | 0 | -40 | -40 |
| Financing Cash Flow | $37,555 | $25,225 | $2,456 | $12,077 | $7,637 |
| Beginning Cash Position | 10,195 | 10,195 | 10,195 | 11,453 | 11,453 |
| End Cash Position | 36,405 | 27,755 | 9,277 | 10,195 | 9,032 |
| Net Cash Flow | $26,210 | $17,560 | $-918 | $-1,258 | $-2,421 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,191 | -7,665 | -3,374 | -13,268 | -9,991 |
| Capital Expenditure | -154 | N/A | N/A | -68 | -68 |
| Free Cash Flow | -11,345 | -7,665 | -3,374 | -13,335 | -10,058 |